Upload Avatar (500 x 500)
Xiaokun Zhang
Life Science
Xiamen University
Fujian
Language: English, Chinese
Nuclear Receptors
Rxr
Retinoids
Cancer Therapy
Apoptosis
Signaling Pathways
Drug Development
Patented Drugs
Targretin
Non-Genomic Mechanisms
Areas of Focus
- Nuclear hormone receptors
- Vitamin A and retinoids in cancer therapy
- Apoptosis signaling pathways
Work Experience
- 1989 - 2006 - Sanford-Burnham Institute for Medical Research - Postdoctoral, Assistant Professor, Associate Professor, Professor
- 2006 - Present - Xiamen University - Dean of Biomedical Research Institute, Dean of School of Pharmacy, Professor of School of Life Sciences
Academic Background & Achievements
- 1982 - Bachelor's Degree in Biology: Xiamen University
- 1989 - Ph.D. in Biochemistry: University of Vermont
- Developed the first anti-cancer patented drug targeting nuclear receptor RXR, Targretin®
